PHYTOGENIC INFINITE POWDER FOUNDATION description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

PHYTOGENIC INFINITE POWDER FOUNDATION

THEFACESHOP CO., LTD.

Drug Facts




FULL PRESCRIBING INFORMATION

Active ingredient

Active Ingredient: TITANIUM DIOXIDE

Inactive Ingredients:

MICA, TALC, SILICA, NYLON-12, DIISOSTEARYL MALATE, PENTAERYTHRITYL TETRAISOSTEARATE, HYDROGENATED POLY(C6-14 OLEFIN), ETHYLHEXYL METHOXYCINNAMATE,
METHICONE, DIMETHICONE, CAPRYLIC/CAPRIC TRIGLYCERIDE, IRON OXIDES(CI77491), HYDROGENATED LECITHIN, DEA-C8-18 PERFLUOROALKYLETHYL PHOSPHATE,
METHYLPARABEN, FRAGRANCE, IRON OXIDES(CI77499), PROPYLPARABEN, HEXYL CINNAMAL, MONTMORILLONITE, ALUMINUM STARCH OCTENYLSUCCINATE, HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER, BUTYLPHENYL METHYLPROPIONAL, HYDROXYISOHEXYL 3-CYCLOHEXENE CARBOXALDEHYDE, HYDROXYCITRONELLAL

Warnings:
When using this product
    Keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
    Rash or irritation develops and lasts.


Directions:

    Apply evenly before sun exposure and as needed.
    Children under 6months of age; ask a doctor.

PHYTOGENIC INFINITE POWDER FOUNDATION

PHYTOGENIC INFINITE POWDER FOUNDATION

TITANIUM DIOXIDE POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:51523-034
Route of Administration CUTANEOUS DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 1.68 g

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:51523-034-01 12 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2009-06-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.